Pricing & Procurement Governance

Examination of how pricing rules, procurement structures, and negotiation mechanisms influence market conditions and long-term price anchoring.

Sep 13, 2023

Wonder Sir Founder Chen Yiwei on China’s Rare Disease Definition and Recent Policy Boost for Foreign CGT Investment

Motivated by a profound sense of purpose and deeply moved by the suffering of Chinese rare disease patients, Chen Yiwei,

Sep 13, 2023

Aug 02, 2023

China Implements More Moderate and Predictable Price Reduction for Older NRDL-Negotiated Drugs

In late June, the National Healthcare Security Administration (NHSA) commenced the 2023 National Reimbursement Drug List (NRDL) Dynamic Update, aiming

Aug 2, 2023